According to Market Research Future®, the Regadenoson Market Size was estimated at USD 500 million in 2024 and is expected to grow from USD 500 million in 2025 to USD 1.5 billion by 2035, expanding at a CAGR of 10.6%. Increasing cardiovascular diagnostic procedures, growing demand for advanced stress testing solutions, rising research activities, and healthcare technology improvements are...